Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug
Motley Fool
Sat, 09/7/19 - 06:16 pm
Tags:
FTC, Amgen, Celgene, Bristol-Myers Squibb, M&A, Otezla
4 Biotech Stocks With Big Catalysts in September
Motley Fool
Thu, 09/5/19 - 10:14 pm
Tags:
Amgen, AMG 510, Mirati Therapeutics, MRTX849, Eli Lilly, LOXO-292, Blueprint Me, Pralsetinibdicines
Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share
Fierce Pharma
Thu, 09/5/19 - 10:37 am
Tags:
Amgen, CGRPs, Aimovig, migraines, Eli Lilly, Emgality
Amgen’s ‘White Whale’ Cancer Data May Send Shares to Record High
Bloomberg
Wed, 09/4/19 - 10:20 am
Tags:
Amgen, AMG 510, colon cancer, non-small cell lung cancer
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Xconomy
Sat, 08/31/19 - 08:00 pm
Tags:
patents, Alexion, Amgen, biosimilars, USPTO
Alexion shares slide on Amgen patent challenge to top-seller
Biopharma Dive
Fri, 08/30/19 - 01:00 pm
Tags:
Amgen, Alexion, inter partes review, patents, Soliris
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Wed, 08/28/19 - 10:52 pm
Tags:
Sanofi, Regeneron, Amgen, PCSK9 inhibitors, patents, Praluent, Repatha
Yes, Amgen overpaid for Otezla—but that doesn't make it a mistake: analysts
Fierce Pharma
Wed, 08/28/19 - 12:47 pm
Tags:
Amgen, Otezla, Enbrel, drug reps, M&A, Celgene
Amgen puts out welcome mat for Celgene’s Otezla reps, but will they join—and then stay?
Fierce Pharma
Wed, 08/28/19 - 10:58 am
Tags:
Amgen, Otezla, drug reps, M&A
Six burning Otezla questions
EP Vantage
Tue, 08/27/19 - 10:53 pm
Tags:
Celgene, Otezla, Amgen, drug pricing, FTC, Tyk2, Bristol-Myers Squibb
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Fierce Pharma
Tue, 08/27/19 - 12:04 pm
Tags:
Amgen, Regeneron, Sanofi, Praluent, Repatha, Medicines Company, PCSK9 inhibitors, inclisiran
Celgene's $13.4 Billion Deal With Amgen Is a Win-Win-Win
Motley Fool
Mon, 08/26/19 - 10:56 pm
Tags:
Amgen, Celgene, Otzela
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Stat
Mon, 08/26/19 - 10:24 am
Tags:
Amgen, Otezla, Celgene, M&A, Bristol-Myers Squibb, psoriasis
Should Amgen Finally Buy Alexion Pharmaceuticals?
Yahoo/Motley Fool
Sun, 08/25/19 - 05:00 pm
Tags:
Amgen, Alexion, M&A
Why Alexion Makes Sense As A Target, But Amgen Doesn't As A Buyer
Investors Business Daily
Sat, 08/24/19 - 11:14 am
Tags:
Amgen, Alexion, M&A
3 Reasons Why Amgen Could Actually Acquire Alexion
Motley Fool
Sat, 08/24/19 - 11:10 am
Tags:
Alexion, Amgen, M&A
Biotech Giant Amgen Could Be Nearing A Massive Takeover: Report
Investors Business Daily
Thu, 08/22/19 - 05:07 pm
Tags:
Amgen, Alexion Pharmaceuticals, M&A
Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study
Endpoints
Thu, 08/22/19 - 11:54 am
Tags:
Novartis, Amgen, Allergan, biosimilars, Roches, Rituxan, ABP 798
Amgen biosimilar debut boosted by UnitedHealthcare coverage switch
Biopharma Dive
Mon, 08/19/19 - 11:52 am
Tags:
insurers, Amgen, biosimilars, Avastin, Herceptin, Roche, UnitedHealthcare
Biopharma's biggest sellers – the oldies that just keep giving
Evaluate Pharma
Sat, 08/17/19 - 01:38 pm
Tags:
Amgen, Enbrel, patents, biologics, Advair, Zantac, Liptor, Plavix

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.